Allarity Therapeutics ALLR
NASDAQ ALLR
$0.88 +0.00 (+0.02%)
As of: Oct 22, 2026 · 9:59 AM EDT

Allarity Therapeutics (ALLR) Operating Margin (2020 - 2026)

Updated

Allarity Therapeutics (ALLR) recorded Operating Margin of -10752.00% in Q1 2026.

Analysis

Allarity Therapeutics (ALLR) Operating Margin (2020 - 2026) Analysis & Trends

For FY2025, Allarity Therapeutics reported Operating Margin of -3939.06%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 28.21%
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn 37.86%
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 20.57%
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn -133.21%
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 28.37%
10 Allarity Therapeutics 14.00 Mn -54.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -10,752.00%
Sep 30, 2021 -14,192.86%
Sep 30, 2020 -786.43%
API Access

Allarity Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEY